Bayesian algorithm. 3DSlicer TM was used to semi-automatically delineate the anatomical volumes on low-dose CT components. Two quantization methods were considered: a quantization into a set number of bins (quantizationB) and an alternative quantization with bins of fixed width (quantizationW). Four shape descriptors, ten firstorder metrics and 26 textural features were computed. Bland-Altman analysis was used to quantify repeatability. Features were subsequently categorized as very reliable, reliable, moderately reliable and poorly reliable with respect to the corresponding volume variability.
INTRODUCTION
The crucial role of positron emission tomography/computed tomography (PET/CT) with fluorine-18 fluorodeoxyglucose (FDG) for diagnosis and staging of non-small cell lung cancer (NSCLC) is established (1) . Tumor metabolism is usually quantified with standardized uptake value (SUV) metrics (e.g., maximum and mean) in PET, whereas the low-dose CT component's role is limited to PET attenuation correction and anatomical localization.
Radiomics denotes the extraction of intensity, shape and heterogeneity features from medical images (2) . Its application to PET (3) and CT (4) has gained interest for characterizing NSCLC tumors quantitatively, with potentially higher value than standard metrics, with the opportunity to combine features from both PET and low-
dose CT components (5).
A first challenge is that numerous features can be calculated, most of which are sensitive to image noise, segmentation or reconstruction settings (7) (8) (9) (10) (11) . Their use for therapy response monitoring and early prediction faces another challenge:
repeatability. Because metrics calculated in pre-, mid-and post-therapy images need to be compared, test-retest repeatability allows determining the cut-off above which a change is attributed to response or progression. This has been estimated at ±15% to 30% for SUV and volume (12, 13) . Regarding shape and heterogeneity metrics, several studies have investigated their repeatability in PET with FDG or fluorine -18 fluorothymidine (8, (14) (15) (16) (17) and in diagnostic CT (18, 19) , dosimetry CT (4, 18) , contrastenhanced CT (CE-CT) (18, 20) or cone-beam CT (CBCT) (21) . These studies exploited small single-center cohorts [n=8 CE-CT (20) , n=10 CBCT (21), n=11 FDG-PET (8, 15, 17) , n=11 fluorine-18 fluorothymidine-PET (16) , n=16 FDG-PET (14) , n=20 CT and 13 CE-CT (18) and n=31 CT (4, 19) ] and never reported on the repeatability of features from the low-dose CT from PET/CT, which is important when combining features from both components (5).
Finally, it has been shown recently that the image quantization step in the calculation of textural features can have an impact on the relationship to other parameters (3) and on the repeatability (17, 22) .
The primary goal of the present work was to evaluate the repeatability of shape and heterogeneity metrics from both PET and low-dose CT components in a large prospective multi-center cohort. A secondary goal was to evaluate the impact of the quantization step.
MATERIALS AND METHODS

Patient cohort and imaging
Patients with stage IIIB-IV NSCLC were prospectively included in the multicenter Merck MK-0646-008 (40 patients in 17 sites) and American College of Radiology Imaging Network (ACRIN) 6678 (34 patients in 14 sites) trials (NCT00424138 and NCT00729742, respectively) (23) . Centers had to conform to the criteria of ACRIN PET qualification (www.acrin.org/6678_protocol.aspx) to participate.
Merck used a similar accreditation program. PET/CT protocols were designed in accordance with National Cancer Institute guidelines (24) . The institutional review board of each participating site approved the study, and all subjects signed a written informed consent form. The whole cohort of 74 patients has been previously included in (23) , but only SUV measurements were analyzed whereas in this present analysis, texture features and shape parameters were also computed both on PET and CT images. The present secondary analysis of deidentified PET/CT images from these trials was approved by ACRIN and was performed in compliance with the Health Insurance Portability and Accountability Act.
PET and CT analysis
In both test-retest datasets, the PET and the low-dose CT images were processed independently. In PET, the metabolically active volumes (MAV) of the primary tumor and up to three additional lesions were segmented with the Fuzzy Locally Adaptive Bayesian algorithm previously validated for accuracy and robustness (25, 26) . In low-dose CT, the anatomical volume (AV) of primary tumors were delineated with a validated semi-automatic approach using 3D Slicer TM (27) . Additional lesions were analyzed if they could be reliably delineated.
The following metrics were calculated on the delineated volumes. Table 1 contains a glossary. All features are described with their calculation formulae (3) in the Supplemental Material.
3D shape descriptors were included, such as sphericity, irregularity or major axis (4, 28) . 2 nd -order metrics from grey-level co-occurrence matrix (GLCM) and neighborhood grey-tone difference matrix (NGTDM), and 3 rd -order metrics from greylevel zone size matrix were calculated in a single matrix considering all 13 orientations simultaneously (30, 31) . Quantization was performed in a set number of bins B (denoted from here onwards quantizationB), as previously recommended (14, 18, 30, 32) using equation 1:
Where Imax and Imin denote maximum and minimum intensity (Hounsfield units in lowdose CT and SUV in PET), and B is the number of bins (here B=64). Choosing a different B value can have an impact on the repeatability of features (14) . Results obtained with B=8 to 128 are in the Supplemental Material. It has been suggested that an alternative quantization using fixed-width bins (e.g., 0.5 SUV) can have an important impact (17, 22) . Results using this approach (denoted from here onwards quantizationw) following equation 2 were also generated.
Where W is the bin width (here 0.5 SUV for PET (22) and 10 Hounsfield units for lowdose CT). Note that W=0.25 SUV and W=5 Hounsfield units were also tested but no significant differences were observed. Supplemental Figure 1 shows a NSCLC tumor with both PET and low-dose CT, and the corresponding quantization results and histograms.
Statistical analysis
Statistical analyses were performed with MedCalc TM (MedCalc Software, Belgium). The repeatability of each metric was assessed with Bland-Altman analysis by reporting the mean and standard deviation (SD) of the differences between the two measurements. Lower and upper repeatability limits were calculated as ±1.96×SD after log-transformation when not normal. Bland-Altman analysis was preferred over intraclass correlation coefficients based on previous recommendations (33) . Intra-class correlation coefficients are nonetheless provided in the Supplemental Material.
Correlations between metrics were assessed with Spearman rank coefficients (rs).
Each metric was also categorized with respect to the repeatability (SD) of the corresponding volume of interest (VOIrepSD): very reliable (≤0.5×VOIrepSD), reliable (>0.5×VOIrepSD and ≤1.5×VOIrepSD), moderately reliable (>1.5×VOIrepSD and ≤2×VOIrepSD) and poorly reliable (>2×VOIrepSD).
RESULTS
The analysis was performed in 73 datasets because one was not available. In the PET images, 73 primary tumors and 32 additional lesions (nodal or distant metastases) were analyzed. Mean MAV was 47.8 cm 3 (median 24.9 cm 3 , SD 55.4 cm 3 ). In the low-dose CT, 2 patients were excluded because visual assessment of images indicated that repeatable volume delineation could not be ensured (Supplemental Fig. 2 ). Seventy-one primary tumors and 5 additional lesions were analyzed. Mean AV was 52.4 cm 3 (median 37.5 cm 3 , SD 53.0 cm 3 ). . 
PET and low-dose CT volumes
As shown in Figure 1 , MAV determination had a repeatability of -1.4±11.1%, with upper and lower repeatability limits of +20.3% and -23.2%, which was dependent on MAV, smaller volumes exhibiting significantly (rs=-0.41, p<0.0001) poorer repeatability. The AV determination had a similar repeatability of -0.4±10.5%, with upper and lower repeatability limits of +20.3% and -21.0%. Repeatability was less dependent on volume (rs=-0.32, p=0.006).
PET (respectively low-dose CT) features were thus categorized with similar thresholds for reliability: ≤5.6% (respectively 5.3%), >5.6% (respectively 5.3%) and ≤16.7% (respectively 15.8%), >16.7% (respectively 15.8%) and ≤22.2% (respectively 21%) and >22.2% (respectively 21.0%).
PET features Shape descriptors and 1 st -order metrics
Overall, the shape features in PET were very repeatable (Fig. 2 ). Irregularity and sphericity were very reliable, with only 4.8% SD. 3D surface and major axis were reliable although with higher variability (9.0% and 8.4%, respectively). Amongst intensity-based 1 st -order features, the most repeatable were CHAUC (-0.2 ± 3.6%) and entropyHIST (-0.2 ± 3.6%), whereas the least repeatable were energy (-1. 
nd -order metrics
As shown in Figure 3 , with quantizationB, amongst GLCM features, entropyGLCM (-0.1 ± 2.6%), sum entropy (-0.2 ± 2.1%) and difference entropy (-0.2 ± 3.0%) were the most repeatable, whereas most other features fell in the reliable category. Five were categorized as moderately reliable and 3 as unreliable. For correlation the very poor repeatability is due to a few outliers for values around zero, to which Bland-Altman is very sensitive. After excluding them, correlation had reproducibility limits below ±20%
and could be re-categorized as moderately reliable. The five NGTDM features were less repeatable than the best GLCM features although still categorized as reliable, all achieving SD ~14-17%, except contrastNGTDM (27.6%).
The use of the alternate quantizationW changed both the above hierarchy and the absolute repeatability of the features. Overall, features calculated after quantizationW were much less reliable with notably more outliers, all exhibiting a higher variability than MAV.
As shown in figure 4 , amongst 3 rd -order metrics, quantization had a similar impact: with quantizationW all grey-level zone size matrix features were categorized as poorly reliable, whereas with quantizationB two were very reliable (small zone size emphasis and zone size percentage with SD <4%) and 3 reliable (large zone size emphasis, gray-level non-uniformity and zone size non-uniformity with SD ~11-14%).
Amongst the least repeatable features were those focusing on small zones and/or low grey values (e.g., LZLGE, SZLGE and LGLZE).
Low-dose CT features Shape descriptors and 1 st -order metrics
As shown in Figure 2 , morphological irregularity, sphericity and 3D surface were the most repeatable (SD 3.3%, 10.0% and 11.6%, respectively). Major axis was less reliable (3.8 ± 18.4%).
On the one hand, four histogram metrics showed poor reliability such as maximum (4.7 ± 38.6%) and mean (-4.2 ± 43.6%) intensity, kurtosis (4.8 ± 37.4%) and skewness (11.1 ± 202.2%). On the other hand, entropyHIST and CHAUC were very reliable (-0.1 ± 2.5% and 0.7 ± 9.1%).
nd -order metrics
The repeatability depended strongly on the quantization, quantizationw improving the repeatability compared to quantizationB (Fig. 3) . Amongst GLCM metrics, the most repeatable (for quantizationB vs. quantizationw, respectively) were entropyGLCM (-1.9 ± 12.0% vs. -0.4 ± 5.2%), sum entropy (-1.4 ± 10.0% vs. 0.1 ± 0.4%) and difference entropy (-2.3 ± 13.1% vs. -0.3 ± 1.9%). To a lesser extent, the same was observed for NGTDM, with higher repeatability using quantizationw. Complexity was the only parameter with variability <15.8% and categorized as reliable (0.5 ± 14.3% and -0.5 ± 12.3% with quantizationB and quantizationw, respectively).
The quantization method also had an important impact (Fig. 4) . Eight parameters were categorized as moderately reliable or better with quantizationw and only two with quantizationB. Small zone size emphasis (-0.6 ± 4.8% vs. -0.5 ± 2.6%
with quantizationB and quantizationw, respectively) and zone size emphasis (-2.8 ± 17.4% vs. -0.9 ± 11.9%) were the most repeatable features (Figs. 4D and 4E ).
Impact of quantization method
Overall, the inverted impacts of the quantization method observed in PET and low-dose CT can be explained by the different correlative relationships between the features and the corresponding volume and maximum intensity. In PET, we observed that quantizationW features were correlated with SUVmax and not with MAV. On the contrary, features calculated with quantizationB were correlated with MAV but not SUVmax. The higher repeatability obtained with quantizationB can thus be explained by the fact that MAV repeatability was much higher than that of SUVmax. Contrary to PET, features in low-dose CT were correlated with both volume and maximum intensity using quantizationB, whereas they were less or not correlated with either volume or intensity using quantizationW. Because maximum intensity had a much worse repeatability than volume in CT, quantizationB thus led to worse repeatability. This is illustrated in Figure 5 for the feature dissimilarity. Note the relative inversion of relationships with volume and SUVmax for quantizationB compared to quantizationW in the case of the PET component. On the contrary for the low-dose CT component, quantizationB led to a higher correlation with maximum intensity than volume, but quantizationW led to lower correlation with volume and non-significant correlation with maximum intensity.
DISCUSSION
In the present work, 73 test-retest PET/CT acquisitions from 31 centers (17 for ACRIN in the USA and 14 for Merck in Asia and Europe) were analyzed for repeatability.
A similar variability of volume delineations was observed for both modalities.
MAV from PET were slightly smaller than AV measured in CT, mostly due to the fact that more lymph nodes and metastases were delineated in PET than in CT, and some large CT volumes had parts without FDG uptake. Regarding SUVmean and SUVmax, our results differ slightly from those previously published in the same cohort (23) . Only lesions with SUVmax>4 were included in the previous analysis, whereas we did not restrict it. By restricting to SUVmax>4, our test-retest results for SUVmax were similar to those previously reported.
Regarding shape and heterogeneity features, our results confirm prior findings in PET (8, (14) (15) (16) (17) . To the best of our knowledge, our study is the first to report on the repeatability of these features in the low-dose CT component.
Overall, the geometric features (shape descriptors) were found reliable (some with high repeatability) in both modalities, which can be related to the high repeatability of segmentation. This is in line with previous findings for PET (8, 17) and with morphological shape in other CT modalities (4). We emphasize that only one segmentation by one expert was considered. The variability might be higher when considering different segmentation approaches and/or several observers.
Regarding 1 st -order metrics and textural higher-order features, our results confirm that the repeatability varies greatly amongst metrics. On the one hand, several features were confirmed to be unreliable in both modalities and should be systematically avoided, e.g., 1 st -order skewness, 2 nd -order Angular Second Moment, contrastGLCM and contrastNGTDM, and 3 rd -order metrics quantifying low grey values and/or small zones. On the other hand, it should be emphasized that several features were identified as reliable, in all three categories and for both modalities. In between,
other features with moderate repeatability should be used with caution as they exhibit larger variability than the corresponding volume determination.
We compared two different quantization methods. QuantizationB is most often used. The impact of choosing another B value has been evaluated previously (14) and our results confirm these findings. Although B=64 is a good compromise and most features exhibited similar repeatability with different values, repeatability of some metrics depended on B. We observed a different impact in PET and low-dose CT for quantizationW, as it led to worse repeatability in PET but better repeatability in lowdose CT. This was explained by the different relationships between the features and the corresponding volume and maximum intensity. With more control over data acquisition and higher repeatability of SUVmax, quantizationW may lead to higher repeatability. These results highlight the major impact of the quantization step and its variable impact depending on image modality that should thus not be overlooked.
Our results confirm that studies building clinical models by combining features from PET/CT images should carefully account for repeatability. This is mandatory when calculating evolution of features across pre-, mid-and/or post-therapy images. This is nonetheless an important factor when building models based on single timepoint images, as models built using robust and repeatable features are more likely to be generalizable and achieve good performance in external/testing cohorts.
Repeatability is not the only criterion on which feature selection needs to be based, as discriminative power, robustness and redundancy have to be considered also.
Our study has limitations. Low-dose CT and PET images were analyzed separately using different segmentation processes performed independently on the test and re-test images. The repeatability evaluation therefore includes the intrinsic repeatability of the segmentation. We used robust segmentation approaches that should minimize variability. Another approach would consist in defining the volume on the test image and register it on the re-test image, which however requires accurate registration and raises other issues (34) . In a clinical environment, the use of less accurate and less robust segmentation could lead to a lower repeatability, especially for volume-correlated features.
We chose to categorize the repeatability levels of each metric with respect to that of the corresponding volume. The repeatability acceptance was similar for both modalities (reliability in PET was defined as SD below 16.5%, compared to 15.8% for low-dose CT). These thresholds are arbitrary and choosing different values would change the categorization of several metrics, but without changing their hierarchy. (dissimilarity from GLCM) and volume (first row) or maximum intensity (second row), in both PET (first column) and low-dose CT (second column) components, depending on the quantization approach.
